Omnipod 5 Fully Available in the US
Insulet recently announced that the Omnipod 5 automated insulin delivery (AID) system is now fully available to anyone with type 1 diabetes ages 2 and up. Read about Omnipod’s features and how to get the new pump today.
The much-anticipated launch of the Omnipod 5 automated insulin delivery (AID) system is now here!
The full launch of Omnipod 5 follows the system’s FDA clearance in January 2022. Since then, the system has been released in a limited launch through select participating pharmacies.
What is the Omnipod 5?
The Omnipod 5 AID system includes three components:
A tubeless, wearable insulin pump that is worn for up to three days and holds 200 units of insulin. The pump comes embedded with the AID algorithm.
A Dexcom G6 continuous glucose monitor (CGM)
The Omnipod 5 mobile app. The app is available on Android smartphones or pre-downloaded on a controller provided by Insulet, and allows users full control over basal and bolus rates, directly from the app.
Insulet is continuing to develop an iPhone (iOS) version of the app and compatibility with Abbott Freestyle Libre CGMs.
How to Set Up Omnipod 5
Learning to use the technological features of a new system can be a challenge, especially for those transitioning to AID from another form of insulin delivery. To set up your Omnipod 5 system, Insulet provides a series of short training modules for the initial setup, pod activation, connecting your CGM, programming alarms, and more.
How much does Omnipod 5 cost?
The AID system is available through retail and mail-order pharmacies for anyone with insurance coverage and a prescription from their healthcare provider. Co-pay costs vary based on the type of insurance.
To check your insurance coverage, talk to your healthcare provider and ask them to send prescriptions for the Omnipod 5 G6 intro kit and the Omnipod 5 G6 pods to ASPN Pharmacies. ASPN will check your coverage, identify your co-pay, and direct your prescription to the pharmacy of your choice. The mobile app can be downloaded at no additional cost from the Google Play Store, or is available pre-programmed on the controller provided by Insulet.
The new system can also be purchased out of pocket through retail pharmacies, or through Costco for Costco members. For existing users of the Omnipod DASH system, Insulet’s OmnipodPromise program allows users to upgrade to the new system for free.
Clinical trial results published in 2021 demonstrated that for people ages 14-70, using the Omnipod 5 system helped increase Time in Range by an average of 2.3 hours per day. For children ages 6-13, the improvement was even more significant, at 3.5 hours per day. The data also suggested that for people with type 1 diabetes using the Omnipod 5 system can improve overall quality of life.
On Aug. 22, the FDA cleared the system for young children ages 2-5. In a recent study of the Omnipod 5 system in this age group, the system helped increase Time in Range by an average of 2.6 hours per day. Also, throughout the entire 13-week trial, there was not a single instance of severe hypoglycemia or diabetic ketoacidosis (DKA) in children using the Omnipod 5 system.
To learn more about the new technical features of Omnipod 5 and past clinical trial results, check out these resources: